Listing 3 - Actual negotiations

Indication:

In combination with obinutuzumab for the treatment of adult patients with previously untreated chronic lymphocytic leukemia (CLL) who are fludarabine ineligible.

Indication:

Spinal Muscular Atrophy

Indication:

Chronic Lymphocytic Leukemia (CLL) (previously untreated): With or without obinutuzumab, for the treatment of patients with previously untreated chronic lymphocytic leukemia (CLL) for whom a fludarabine-based regimen is inappropriate

Indication:

Chronic Lymphocytic Leukemia: As monotherapy for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.

Indication:

Asthma

Indication:

Asthma

Indication:

Acute myeloid leukemia (AML) Newly diagnosed in patients who are 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy (In combination with low-dose cytarabine)

Indication:

Conception Control

Indication:

Cystic Fibrosis, F508del CFTR mutation

Indication:

Migraine, Chronic